Readystate Asset Management »

Inhibrx shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $526k 14k 38.00

More positions owned by Readystate Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Pfizer Call Option (PFE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Wolfspeed Note 1.875%12/0 (Principal)
Select Sector Spdr Tr Financial (XLF)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Alphatec Hldgs Note 0.750% 8/0 (Principal)
Veradigm Note 0.875% 1/0 (Principal)
Builders FirstSource Put Option (BLDR)
Peabody Energy Corp Note 3.250% 3/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Inhibrx

Viking Global Investors
RA Capital Management
Perceptive Advisors
Vanguard Group
Arrowpoint Asset Management
Bank of America Corporation
Logos Global Management
Partner Fund Management
Russell Investments
Citadel Advisors
Caption Management
Millennium Management
Charles Schwab Investment Management
Sphera Funds Management
Two Sigma Advisers

View all funds holding Inhibrx